Occurrence of emerging organic contaminants and endocrine disruptors in different water compartments in Mexico - A review.

This review compiles the studies (2007-2021) regarding the occurrence of emerging organic contaminants (EOCs) and endocrine disruptors (EDs) in wastewater, surface water and groundwater in Mexico. A total of 174 compounds were detected, including pharmaceuticals, hormones, plasticizers, personal care products, sweeteners, drugs, and pesticides considered as EDs. The levels of EOCs and EDs varied from ng/L to 140 mg/L, depending on the compound, location, and compartment. Raw wastewater was the most studied matrix, showing a greater abundance and number of detected compounds. Nevertheless, surface waters showed high concentrations of bisphenol-A, butylbenzil-phthalate, triclosan, pentachlorophenol, and the hormones estrone, 17 α-ethinylestradiol, and 17 β-estradiol, which exceeded the thresholds set by international guidelines. Concentrations of 17 α-ethinylestradiol and triclosan exceeding the above-mentioned limits were reported in groundwater. Cropland irrigation with raw wastewater was the principal activity introducing EOCs and EDs into groundwater. The groundwater abundance of EOCs was considerably lesser than that of wastewater, highlighting the attenuation capacity of soils/aquifers during wastewater infiltration. However, carbamazepine and N,N-diethyl-meta-toluamide showed higher concentrations in groundwater than those in wastewater, suggesting their accumulation/concentration in soils/pore-waters. Although the contamination of water resources represents one of the most environmental concerns in Mexico, this review brings to light the lack of studies on the occurrence of EOCs in Mexican waters, which is important for public health policies and for developing legislations that incorporates EOCs as priority contaminants in national water quality guidelines. Consequently, the development of legislations will support regulatory compliance for wastewater and drinking water, reducing the human exposure.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)